| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0031995 | MF | insulin-like growth factor II binding | Interacting selectively and non-covalently with insulin-like growth factor II. |
INSR, IGFBP1, IGF2R, IGFBP3, IGFBP2, IGFBP4, IGFBP6, IGFBP5 |
GO:0031996 | MF | thioesterase binding | Interacting selectively and non-covalently with any thioesterase enzyme. |
CDC42, CALM2, RAC1, TRAF1, HAUS7 |
GO:0031997 | MF | N-terminal myristoylation domain binding | Interacting selectively and non-covalently with the N-terminus of a protein that has the potential to be, or has been, modified by N-terminal myristoylation. Binding affinity is typically altered by myristoylation; for example, N-terminal myristoylation of HIV Nef increases its affinity for calmodulin. |
CALM2 |
GO:0031998 | BP | regulation of fatty acid beta-oxidation | Any process that modulates the frequency, rate or extent of fatty acid bbeta-oxidation. |
LONP2 |
GO:0031999 | BP | negative regulation of fatty acid beta-oxidation | Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid beta-oxidation. |
ACACB, CNR1, AKT1, PLIN5 |
GO:0032000 | BP | positive regulation of fatty acid beta-oxidation | Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation. |
AKT2, IRS1, CPT1A, PLIN5, PPARA, TWIST1, IRS2 |
GO:0032002 | CC | interleukin-28 receptor complex | A protein complex that binds interleukin-28 and interleukin-29. It is composed of an alpha and a beta receptor subunit (in human IFNLR1/IL28Ralpha & IL10RB) and either Interleukin-28 (IFNL2 or IFNL3) or Interleukin-29 (IFNL1). |
IL10RB |
GO:0032006 | BP | regulation of TOR signaling | Any process that modulates the frequency, rate or extent of TOR signaling. |
GNA12, GPAT3, FLCN, RFFL, FAM83D, RRAGC, FBXO9 |
GO:0032007 | BP | negative regulation of TOR signaling | Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling. |
ARNTL, PDCD6, EPM2A, TSC2, PRKAA2, NPRL3, MTM1, HIF1A, UBR1, FLCN, DEPTOR, FNIP1, TNFAIP8L1, DDIT4, SH3BP4 |
GO:0032008 | BP | positive regulation of TOR signaling | Any process that activates or increases the frequency, rate or extent of TOR signaling. |
HDAC3, LEP, SEC13, GAS6, RHEB, LAMTOR1, RICTOR, SLC38A9, FLCN, SEH1L, MLST8, RRAGC, RRAGD, LAMTOR3, LAMTOR2 |
GO:0032009 | CC | early phagosome | A membrane-bounded intracellular vesicle as initially formed upon the ingestion of particulate material by phagocytosis. |
SNX3, SYK, SYT11 |
GO:0032010 | CC | phagolysosome | A membrane-bounded intracellular vesicle formed by maturation of an early phagosome following the ingestion of particulate material by phagocytosis; during maturation, phagosomes acquire markers of late endosomes and lysosomes. |
NCF2, ADAM8, NCF4 |
GO:0032012 | BP | regulation of ARF protein signal transduction | Any process that modulates the frequency, rate or extent of ARF protein signal transduction. |
CYTH3, ARFGEF3, IQSEC1, GBF1, FBXO8, PSD3, ARFGEF2 |
GO:0032020 | BP | ISG15-protein conjugation | The covalent addition to a protein of ISG15, a ubiquitin-like protein. |
ISG15, UBA7, UBE2E1, UBE2E2 |
GO:0032024 | BP | positive regulation of insulin secretion | Any process that activates or increases the frequency, rate or extent of the regulated release of insulin. |
JAK2, PFKFB2, RBP4, GJA1, TRH, ABAT, PPARD, SOX4, TARDBP, NR0B2, PCK2, AACS, SLC30A8, MYRIP, BAD, GPER1, CAPN10, TCF7L2, GHRL, IRS2 |
GO:0032025 | BP | response to cobalt ion | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus. |
ALAD, ATF1, CASP9, CASP8 |
GO:0032026 | BP | response to magnesium ion | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. |
TNFRSF11B, ENTPD6, THBS1, CD14, BMP6, SNCA, MDM2 |
GO:0032027 | MF | myosin light chain binding | Interacting selectively and non-covalently with a light chain of a myosin complex. |
CXCR4, MYO19 |
GO:0032036 | MF | myosin heavy chain binding | Interacting selectively and non-covalently with a heavy chain of a myosin complex. |
MYL9, CORO1A, PDLIM2 |
GO:0032038 | MF | myosin II heavy chain binding | Interacting selectively and non-covalently with a heavy chain of a myosin II complex. |
MYL4 |
GO:0032039 | CC | integrator complex | A protein complex that stably associates with the C-terminus of RNA polymerase II and mediates 3'-end processing of small nuclear RNAs generated by RNA polymerase II. |
SHFM1, CPSF3L, INTS3, INTS1, INTS4, INTS7, INTS10, INTS6 |
GO:0032040 | CC | small-subunit processome | A large ribonucleoprotein complex that is an early preribosomal complex. In S. cerevisiae, it has a size of 80S and consists of the 35S pre-rRNA, early-associating ribosomal proteins most of which are part of the small ribosomal subunit, the U3 snoRNA and associated proteins. |
NOP56, UTP20, SNU13, RPS7, TBL3, NGDN, WDR36, EMG1, UTP23, DCAF13, WDR3, FCF1, UTP18 |
GO:0032041 | MF | NAD-dependent histone deacetylase activity (H3-K14 specific) | Catalysis of the reaction: histone H3 N6-acetyl-L-lysine (position 14) + H2O = histone H3 L-lysine (position 14) + acetate. This reaction requires the presence of NAD, and represents the removal of an acetyl group from lysine at position 14 of the histone H3 protein. |
HDAC3, HDAC4, HDAC1, HDAC7, HDAC2, HDAC8, HDAC6, HDAC9, HDAC5 |
GO:0032042 | BP | mitochondrial DNA metabolic process | The chemical reactions and pathways involving mitochondrial DNA. |
PARP1, SESN2 |
GO:0032044 | CC | DSIF complex | A heterodimeric protein complex formed of Spt4 and Spt5 proteins which is expressed in eukaryotes from yeast to man. DSIF is an inhibitory elongation factor that promotes RNA polymerase II transcriptional pausing, but can also stimulate transcriptional elongation under certain conditions, and may play a role in RNA processing via its physical association with mRNA capping enzymes. |
SUPT5H |
GO:0032045 | CC | guanyl-nucleotide exchange factor complex | A protein complex that stimulates the exchange of guanyl nucleotides associated with a GTPase. |
RAP1A, PDE3B, KNDC1, ELMO1 |
GO:0032049 | BP | cardiolipin biosynthetic process | The chemical reactions and pathways resulting in the formation of cardiolipin, 1,3-bis(3-phosphatidyl)glycerol. |
PGS1, SLC27A1, PTPMT1, CRLS1 |
GO:0032050 | MF | clathrin heavy chain binding | Interacting selectively and non-covalently with a clathrin heavy chain. |
LDLR, CLTA, PICALM, CEMIP |
GO:0032051 | MF | clathrin light chain binding | Interacting selectively and non-covalently with a clathrin light chain. |
NSG1 |
GO:0032052 | MF | bile acid binding | Interacting selectively and non-covalently with bile acids, any of a group of steroid carboxylic acids occurring in bile. |
FABP6, AKR1C2, AKR1C1, NR1H4 |
GO:0032053 | BP | ciliary basal body organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a ciliary basal body, a short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum). |
CROCC |
GO:0032055 | BP | negative regulation of translation in response to stress | Any process that stops, prevents or reduces the rate of translation as a result of a stimulus indicating the organism is under stress. |
RBM4 |
GO:0032057 | BP | negative regulation of translational initiation in response to stress | Any process that stops, prevents or reduces the rate of translation initiation as a result of a stimulus indicating the organism is under stress. |
EIF2S1, ATF4, EIF2B5, EIF2B3, EIF2AK4, EIF2B4 |
GO:0032058 | BP | positive regulation of translational initiation in response to stress | Any process that activates or increases the frequency, rate or extent of translation initiation as a result of a stimulus indicating the organism is under stress. |
PPP1R15A |
GO:0032059 | CC | bleb | A cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Blebs are formed during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses. |
TPM1, PANX1, SDF4, FHOD1 |
GO:0032060 | BP | bleb assembly | The assembly of a bleb, a cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Plasma membrane blebbing occurs during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses. |
EMP1, EMP2, EMP3, PMP22, MYLK, ANO6 |
GO:0032066 | BP | nucleolus to nucleoplasm transport | The directed movement of substances from the nucleolus to the nucleoplasm. |
TBRG1, NOC2L |
GO:0032071 | BP | regulation of endodeoxyribonuclease activity | Any process that modulates the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks. |
NPM1 |
GO:0032072 | BP | regulation of restriction endodeoxyribonuclease activity | Any process that modulates the frequency, rate or extent of a restriction endodeoxyribonuclease activity, the catalysis of endonucleolytic cleavage of DNA in a site-specific manner, resulting in double-strand breaks. |
HMGB1 |
GO:0032075 | BP | positive regulation of nuclease activity | Any process that activates or increases the frequency, rate or extent of nuclease activity, the hydrolysis of ester linkages within nucleic acids. |
HMGB2 |
GO:0032077 | BP | positive regulation of deoxyribonuclease activity | Any process that activates or increases the frequency, rate or extent of deoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid. |
PCNA |
GO:0032079 | BP | positive regulation of endodeoxyribonuclease activity | Any process that activates or increases the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks. |
AKT1, PRKCD |
GO:0032088 | BP | negative regulation of NF-kappaB transcription factor activity | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
IRAK2, KLF4, PSMD10, TRIM37, ANXA4, TNFAIP3, DAP, IRAK1, MAP2K5, PTGIS, CYP1B1, COMMD6, TAX1BP1, NLRC5, COMMD1, SETD6, ZNF675, PELI1, ITCH, NR1H4, CHP1, FOXP3, CYLD, NFKBIL1, PYCARD, IRAK3 |
GO:0032090 | MF | Pyrin domain binding | Interacting selectively and non-covalently with a Pyrin (PAAD/DAPIN) domain, a protein-protein interaction domain that has the same fold as the Death domain. |
PYCARD |
GO:0032091 | BP | negative regulation of protein binding | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
ITGB1BP1, AURKA, KDM1A, PEX14, DKK1, PDGFB, SLPI, RALB, ACE, LRPAP1, MAPK8, NES, CSNK1E, GSK3B, PPP1CA, DAB2, CAV1, PRKCD, BAX, PPARA, AES, GOLGA2, TDG, CAMK1, NFATC4, CARM1, TEX14, MITD1, SORL1, AURKB, GNL3L, DACT1, STUB1 |
GO:0032092 | BP | positive regulation of protein binding | Any process that activates or increases the frequency, rate or extent of protein binding. |
KRIT1, FLOT1, GCG, VTN, HSP90AB1, RALB, BMP2, BMP4, ACE, WNT5A, GSK3B, B2M, PKD1, CDK5, CAV1, EP300, TIAM1, STK4, BAMBI, ARHGEF7, HFE, SPPL3, CTHRC1, TRIB3, HIPK2, AKTIP, TCF7L2, DACT1, PLK2, AMFR, PLXND1 |
GO:0032093 | MF | SAM domain binding | Interacting selectively and non-covalently with a SAM (Sterile Alpha Motif) domain, which is a 70-amino acid protein sequence that participates in protein-protein, protein-lipid, and protein-RNA interactions and is conserved from lower to higher eukaryotes. |
L3MBTL1 |
GO:0032094 | BP | response to food | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. |
BCL10, GHRH, CYP1A1, MPO, G6PD, AKT1, G6PC, CHRNA7, SREBF1, HSD11B2, GHSR |
GO:0032095 | BP | regulation of response to food | Any process that modulates the frequency, rate or extent of a response to a food stimulus. |
MT3, GHRL |
GO:0032098 | BP | regulation of appetite | Any process which modulates appetite, the desire or physical craving for food. |
SLC22A3, POMC, HTR2C |
GO:0032099 | BP | negative regulation of appetite | Any process that reduces appetite. |
CCK, LEP, PPARA, CARTPT, SPX, NENF |
GO:0032100 | BP | positive regulation of appetite | Any process that increases appetite. |
GHSR, GHRL |
GO:0032116 | CC | SMC loading complex | A protein complex required for the loading of a structural maintenance of chromosome (SMC) complex, such as cohesin, condensin or SMC5/SMC6, onto DNA. Appears to be eukaryotically conserved. |
NIPBL |
GO:0032119 | BP | sequestering of zinc ion | The process of binding or confining zinc ions such that they are separated from other components of a biological system. |
S100A8, S100A9, SLC30A8 |
GO:0032127 | CC | dense core granule membrane | The lipid bilayer surrounding a dense core granule. |
ADAM8 |
GO:0032133 | CC | chromosome passenger complex | A eukaryotically conserved protein complex that localizes to kinetochores in early mitosis, the spindle mid-zone in anaphase B and to the telophase midbody. It has been proposed that the passenger complex coordinates various events based on its location to different structures during the course of mitosis. Complex members include the BIR-domain-containing protein Survivin, Aurora kinase, INCENP and Borealin. |
AURKA, BIRC5, CDCA8, AURKB |
GO:0032137 | MF | guanine/thymine mispair binding | Interacting selectively and non-covalently with double-stranded DNA containing a G/T mispair. |
MLH1, MSH2, MSH6 |
GO:0032139 | MF | dinucleotide insertion or deletion binding | Interacting selectively and non-covalently with double-stranded DNA containing a dinucleotide insertion or deletion. |
PCNA, MSH3, MSH2 |
GO:0032142 | MF | single guanine insertion binding | Interacting selectively and non-covalently with double-stranded DNA containing a single guanine insertion or a deletion that results in an unpaired guanine. |
MSH3, MSH2, MSH6 |
GO:0032143 | MF | single thymine insertion binding | Interacting selectively and non-covalently with double-stranded DNA containing a single thymine insertion or a deletion that results in an unpaired thymine. |
MSH2, MSH6 |
GO:0032144 | CC | 4-aminobutyrate transaminase complex | A homodimeric protein complex that possesses 4-aminobutyrate transaminase activity. |
ABAT |
GO:0032145 | MF | succinate-semialdehyde dehydrogenase binding | Interacting selectively and non-covalently with succinate-semialdehyde dehydrogenase. |
ABAT |
GO:0032147 | BP | activation of protein kinase activity | Any process that initiates the activity of an inactive protein kinase. |
AXIN1, PDGFB, ITGB3, RPLP1, INSR, DRD2, VEGFA, TGFBR2, PIK3CA, SLC11A1, EMP2, TGFB2, PRKCD, DLG1, ACVR2B, KIF14, STK11, DBF4B, DUSP19, FGF13, STRADB, WNK1, RGCC, ECT2, GPRC5B, TPX2, CAB39 |
GO:0032148 | BP | activation of protein kinase B activity | Any process that initiates the activity of the inactive enzyme protein kinase B. |
ITGB1BP1, PDGFB, INS, ANG, IGF1, INSR, TXN, ADRA2B, MT3, WNT5A, NRG1, IL18, GAS6, CCDC88A, PINK1, OSBPL8 |
GO:0032154 | CC | cleavage furrow | The cleavage furrow is a plasma membrane invagination at the cell division site. The cleavage furrow begins as a shallow groove and eventually deepens to divide the cytoplasm. |
PLK4, RAB11FIP3, STAMBP, ITGB1, RALA, NF2, RDX, MYH9, PPP1CC, RHOA, RAB11A, RHOB, SEPT6, SEPT2, MYLK, SEPT7, PKN1, PKN2, CEP55, MASTL, ZFYVE19, RACGAP1, ECT2, NDE1, LIMA1, RAB21 |
GO:0032173 | CC | septin collar | A tubular, hourglass-shaped structure composed of highly ordered arrays of septin filaments; in budding yeast cells, the septin collar forms from the initial septin ring by expanding into the daughter cell. |
SEPT6 |
GO:0032181 | MF | dinucleotide repeat insertion binding | Interacting selectively and non-covalently with double-stranded DNA containing a dinucleotide repeat insertion or a deletion resulting in unpaired dinucleotide repeats. |
MSH3, MSH2 |
GO:0032182 | MF | ubiquitin-like protein binding | Interacting selectively and non-covalently with a small conjugating protein such as ubiquitin or a ubiquitin-like protein. |
DCUN1D4, DCUN1D1 |
GO:0032183 | MF | SUMO binding | Interacting selectively and non-covalently with the small ubiquitin-like protein SUMO. |
TDG, TOLLIP, USP25 |
GO:0032184 | MF | SUMO polymer binding | Interacting selectively and non-covalently with a polymer of the small ubiquitin-like protein SUMO. |
SOBP, RNF111, SIMC1 |
GO:0032190 | MF | acrosin binding | Interacting selectively and non-covalently with acrosin, a protein that is found in the acrosomes of sperm and possesses protease and carbohydrate binding activities. |
SERPINA5, ZP3 |
GO:0032200 | BP | telomere organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of telomeres, terminal regions of a linear chromosome that include the telomeric DNA repeats and associated proteins. |
HIST1H4A, HIST1H3D, H3F3A |
GO:0032202 | BP | telomere assembly | A cellular process that results in the aggregation, arrangement and bonding together of a set of components to form a telomere at a non-telomeric double-stranded DNA end. A telomere is a terminal region of a linear chromosome that includes telomeric DNA repeats and associated proteins. |
ACD, POT1 |
GO:0032204 | BP | regulation of telomere maintenance | Any process that modulates the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA. |
MYC, HDAC8, PIF1, SMG5 |
GO:0032205 | BP | negative regulation of telomere maintenance | Any process that stops, prevents, or reduces the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA. |
ERCC1, ERCC4 |
GO:0032206 | BP | positive regulation of telomere maintenance | Any process that activates or increases the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA. |
NBN, ATRX, MRE11A, RAD50, GNL3, DHX36 |
GO:0032210 | BP | regulation of telomere maintenance via telomerase | Any process that modulates the frequency, rate or extent of the addition of telomeric repeats by telomerase. |
TNKS, SMG5 |
GO:0032211 | BP | negative regulation of telomere maintenance via telomerase | Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of telomeric repeats by telomerase. |
HNRNPC, HNRNPA1, TERF1, HNRNPU, ACD, PIF1, GNL3L |
GO:0032212 | BP | positive regulation of telomere maintenance via telomerase | Any process that activates or increases the frequency, rate or extent of the addition of telomeric repeats by telomerase. |
MAP2K7, DKC1, TNKS, HNRNPA1, TCP1, MAPK3, MAPK1, CTNNB1, CCT6A, CCT3, CCT8, NEK2, CCT2, PRKCQ, NEK7, ACD, AURKB, CCT7, TNKS2, OBFC1, POT1, MAP3K4 |
GO:0032214 | BP | negative regulation of telomere maintenance via semi-conservative replication | Any process that stops, prevents, or reduces the frequency, rate or extent of the semi-conservative replication of telomeric DNA. |
TERF1 |
GO:0032217 | MF | riboflavin transporter activity | Enables the directed movement of riboflavin into, out of or within a cell, or between cells. Riboflavin (vitamin B2) is a water-soluble B-complex vitamin, converted in the cell to FMN and FAD, cofactors required for the function of flavoproteins. |
SLC52A3 |
GO:0032218 | BP | riboflavin transport | The directed movement of riboflavin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Riboflavin (vitamin B2) is a water-soluble B-complex vitamin, converted in the cell to FMN and FAD, cofactors required for the function of flavoproteins. |
SLC52A3 |
GO:0032224 | BP | positive regulation of synaptic transmission, cholinergic | Any process that activates, maintains or increases the frequency, rate or extent of cholinergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter acetylcholine. |
LAMA2 |
GO:0032225 | BP | regulation of synaptic transmission, dopaminergic | Any process that modulates the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine. |
CHRNA7, PNKD |
GO:0032226 | BP | positive regulation of synaptic transmission, dopaminergic | Any process that activates, maintains or increases the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine. |
FLOT1, PINK1 |
GO:0032227 | BP | negative regulation of synaptic transmission, dopaminergic | Any process that stops, prevents, or reduces the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine. |
PTGS2 |
GO:0032228 | BP | regulation of synaptic transmission, GABAergic | Any process that modulates the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). |
KRAS, DRD2, CNR1, PTEN, USP46, PLCL1, PLCL2, NISCH |
GO:0032229 | BP | negative regulation of synaptic transmission, GABAergic | Any process that stops, prevents, or reduces the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). |
SLC6A1, ADORA1, STXBP1, NPY5R |
GO:0032230 | BP | positive regulation of synaptic transmission, GABAergic | Any process that activates, maintains or increases the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). |
CA2, OXTR, ADRA1A, NLGN1 |
GO:0032231 | BP | regulation of actin filament bundle assembly | Any process that modulates the frequency, rate or extent of the assembly of actin filament bundles. |
RDX |
GO:0032232 | BP | negative regulation of actin filament bundle assembly | Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly of actin filament bundles. |
PARK2, PFN1 |
GO:0032233 | BP | positive regulation of actin filament bundle assembly | Any process that activates or increases the frequency, rate or extent of the assembly of actin filament bundles. |
PFN1, ID1, SYNPO2 |
GO:0032237 | BP | activation of store-operated calcium channel activity | A process that initiates the activity of an inactive store-operated calcium channel. |
PLCG2, STIM2 |
GO:0032244 | BP | positive regulation of nucleoside transport | Any process that activates or increases the frequency, rate or extent of the directed movement of a nucleoside into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
ADORA1 |
GO:0032252 | BP | secretory granule localization | Any process in which a secretory granule is transported to, and/or maintained in, a specific location within the cell. |
PIK3CG, MYO5A |
GO:0032259 | BP | methylation | The process in which a methyl group is covalently attached to a molecule. |
TYMS, PNMT, COMT, GCSH, AHCY, MAT2A, NNMT, HNMT, TPMT, PRDM15, GSTO1, MTAP, NDUFAF5, TYW3, METTL23, SETD9, MTR, DPH5, METTL17, METTL8, METTL7A, AS3MT, PRDM10, METTL5, FAM86C1, COQ3, MAT2B, PEMT, N6AMT1 |
GO:0032261 | BP | purine nucleotide salvage | Any process which produces a purine nucleotide from derivatives of it, without de novo synthesis. |
ADA |
GO:0032264 | BP | IMP salvage | Any process which produces inosine monophosphate from derivatives of it, without de novo synthesis. |
AMPD3 |
GO:0032266 | MF | phosphatidylinositol-3-phosphate binding | Interacting selectively and non-covalently with phosphatidylinositol-3-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' position. |
SH3PXD2B, SNX3, NCF4, WIPI1, TECPR1, DENND1A, PARD3, SNX19, SNX21, ZFYVE19, PLEKHA5, SNX24, WDR45, WIPI2 |
GO:0032268 | BP | regulation of cellular protein metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
PM20D2 |